SUMMARYHistamine, an important inflammatory mediator in allergic diseases and asthma, has been reported to have modulator effects on T cells, suggesting that the bronchial microenvironment may regulate the function of resident T cells. We examined the effect of histamine on the release of the Th2-associated cytokines IL-4 and IL-5 and the Th1-associated cytokine IFN-g by 30 CD4 + T cell clones from peripheral blood or bronchial biopsy of one atopic subject. Based on the IL-4/IFN-g ratio, the clones were ascribed to the Th2 (ratio > 1), Th0 (ratio Ն 0 . 1 and Յ 1) or Th1 (ratio < 0 . 1) phenotype. Histamine inhibited IFN-g production by Th1-like cells (P < 0 . 02, Kruskall-Wallis), especially from bronchial biopsy, but had no effect on IL-4 release. Regarding Th0 clones, histamine inhibited IL-4 production (P < 0 . 02) in a dose-dependent manner and slightly inhibited IFN-g production, but had no effect on Th2-like cells. Histamine had a heterogeneous and insignificant effect on IL-5 production. The H 2 -receptor antagonist ranitidine completely reversed the inhibition of IL-4 and IFN-g production, whereas the agonist dimaprit mimicked this effect. In contrast, H 1 -and H 3 -receptor agonists and antagonists had no significant effect. These data demonstrate that histamine has different effects on IL-4 and IFN-g release by T helper cells according to their phenotype via H 2 -receptors. This study extends the immunomodulatory effects of histamine which may contribute to the perpetuation of airway inflammation in asthma.